Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY Conjugate Vaccine Formulations in Children
NCT00196976Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2005
- Primary completion
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of meningococcal group A, C, W135 and Y conjugate vaccine in meningococcal disease, sponsored by GSK. Started Mar 2005; status: completed.
02
Drugs
meningococcal group A, C, W135 and Y conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00196976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196976.